• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Company wide reorg to align with the new areas (Onc, Vac, Chronic Care)?

anonymous

Guest
What's on the horizon for clinical and basic research with this new announcement? What happens to support staff for infectious diseases? Any word on in licensing within CC area?